Week-by-week injection log (5mg/mL concentration) Print this chart
The impact of orforglipron on blood sugar was comparable with other currently approved diabetes drugs, including metformin, Ozempic, and the tirzepatide drug Mounjaro, according to Zerr
1 If approved, an effective once-daily oral GLP-1 could significantly expand access by lowering delivery barriers, improving adherence for injection-averse patients, and alleviating distribution constraints often associated with injectable formulations
References Bray, F
BPC157 exerts a significant protective effect on various tissues and organs, such as the esophagus, stomach, duodenum (Drmic et al., 2017), colorectal mucosa (Duzel et al., 2017), liver, pancreas (Konturek and Brzozowski, 2008), muscle (Lai et al., 2019), cornea (Lazic et al., 2005), heart (Sikiric et al., 2016) and nerves (Grabarevic et al., 1997